Medline Inc. Class A Common Stock (MDLN) - Total Liabilities
Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has total liabilities worth $20.27 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Medline Inc. Class A Common Stock (MDLN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Medline Inc. Class A Common Stock - Total Liabilities Trend (2023–2025)
This chart illustrates how Medline Inc. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medline Inc. Class A Common Stock total assets.
Medline Inc. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of Medline Inc. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vodafone Group Plc
F:VODJ
|
Germany | €72.25 Billion |
|
Nokia Oyj
HE:NOKIA
|
Finland | €16.37 Billion |
|
BOE Technology Group Co Ltd
SHE:000725
|
China | CN¥227.24 Billion |
|
MongoDB
NASDAQ:MDB
|
USA | $757.73 Million |
|
Nestle India Limited
NSE:NESTLEIND
|
India | Rs80.26 Billion |
|
Extra Space Storage Inc
NYSE:EXR
|
USA | $14.89 Billion |
|
Hannover Rück SE
F:HNR1
|
Germany | €57.40 Billion |
|
China Hongqiao Group Ltd
F:H0Q
|
Germany | €103.67 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down Medline Inc. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Medline Inc. Class A Common Stock's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medline Inc. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medline Inc. Class A Common Stock (2023–2025)
The table below shows the annual total liabilities of Medline Inc. Class A Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $19.20 Billion | -1.32% |
| 2024-12-31 | $19.45 Billion | +1.61% |
| 2023-12-31 | $19.14 Billion | -- |
About Medline Inc. Class A Common Stock
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more